Fortress Biotech, Inc. (FBIO)
1.875
-0.12
(-5.78%)
USD |
NASDAQ |
Nov 13, 16:00
1.875
0.00 (0.00%)
After-Hours: 19:59
Fortress Biotech Market Cap : 62.46M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 66.29M |
| November 11, 2026 | 66.96M |
| November 10, 2026 | 63.62M |
| November 09, 2026 | 66.29M |
| November 06, 2026 | 61.63M |
| November 05, 2026 | 61.29M |
| November 04, 2026 | 65.62M |
| November 03, 2026 | 64.62M |
| November 02, 2026 | 64.29M |
| October 30, 2026 | 63.96M |
| October 29, 2026 | 66.62M |
| October 28, 2026 | 65.29M |
| October 27, 2026 | 64.29M |
| October 26, 2026 | 62.29M |
| October 23, 2026 | 64.29M |
| October 22, 2026 | 66.29M |
| October 21, 2026 | 64.62M |
| October 20, 2026 | 64.62M |
| October 19, 2026 | 62.29M |
| October 16, 2026 | 62.29M |
| October 15, 2026 | 63.62M |
| October 14, 2026 | 63.29M |
| October 13, 2026 | 64.96M |
| October 12, 2026 | 70.29M |
| October 09, 2026 | 71.12M |
| Date | Value |
|---|---|
| October 08, 2026 | 69.62M |
| October 07, 2026 | 67.95M |
| October 06, 2026 | 68.29M |
| October 05, 2026 | 69.62M |
| October 02, 2026 | 67.62M |
| October 01, 2026 | 68.95M |
| September 30, 2026 | 71.29M |
| September 29, 2026 | 73.28M |
| September 28, 2026 | 72.28M |
| September 25, 2026 | 75.95M |
| September 24, 2026 | 75.95M |
| September 23, 2026 | 77.95M |
| September 22, 2026 | 81.61M |
| September 21, 2026 | 80.28M |
| September 18, 2026 | 83.61M |
| September 17, 2026 | 83.61M |
| September 16, 2026 | 81.95M |
| September 15, 2026 | 82.94M |
| September 14, 2026 | 84.28M |
| September 11, 2026 | 83.94M |
| September 10, 2026 | 85.61M |
| September 09, 2026 | 87.61M |
| September 08, 2026 | 90.27M |
| September 04, 2026 | 90.61M |
| September 03, 2026 | 90.27M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 6.741B |
| Nektar Therapeutics | 1.272B |
| DiaMedica Therapeutics, Inc. | 474.01M |
| Journey Medical Corp. | 118.37M |
| ACADIA Pharmaceuticals, Inc. | 3.238B |
Market Cap Related Metrics
| PE Ratio | 0.7058 |
| PS Ratio | 0.9220 |
| Price to Book Value | 0.3806 |
| Price to Free Cash Flow | 0.5248 |
| Price | 1.875 |
| Earnings Yield | 141.7% |
| Normalized PE Ratio | 0.7657 |